European Summit on Neuroscience and Psychiatry October 07-08, 2019 Rome, Italy

Mojtaba Mafi is a physician/Medical Doctor. He received M.D. degree from Tehran university school of Medicine with honors and passed successfully many post graduate Medical education programs approved by Medical Sciences University. He worked clinically in Neurosurgery ward Shariati hospital for Thesis on Brain tumors and Meningioma for 6 years till 2008. He is now active in clinical setting and scientific field. Dr Mojtaba Mafi is invited speaker in Global and European neurosurgery and neurology conferences in Rome, Italy and London. He is invited editorial board member of psychology and neuroscience journal. He is speaker of world congress on neuronal synchronization, London 2018 and speaker of International Neuro oncology conference in Dubai, September 2018. He is honourable speaker of 26th International Neurology conference in Japan. Dr Mojtaba Mafi is Board member of International journal of psychology and neuroscience. Dr Mafi is Speaker of 5th annual conference on stroke and Neurodisorders, Turkey, November 2018.

Hepatology, Liver Diseases, Gastroenterology, Brain Tumor, Alzheimers

He is Chief Executive Officer and Chief Medical Officer of ClinFomatrix, USA and Chief Executive Officer of Cure Pharmaceuticals, Inc., USA. He has more than 17 years of experience in drug development, medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care; Phase 1 – 4, and marketing commercialization of immuno-oncology, hematology, oncology and radio pharmaceutical drugs in USA, EU and Japan. He is leader in Cancer Drug Development Worldwide Phase 2 and 3 clinical trials in many countries. He contributed to 21-INDs and 7-NDAs of Cancer Drugs and supportive care, acquisition /merger of pharma and drug for more than $300 million. He received his clinical, medical training & worked at renowned medical centers and pharmaceutical institutions worldwide; Walter Reed Army Institute of Research and Medical Center, Daiichi, Sumitomo, Pharmacia, Pfizer, Sopherion Oncology., Eisai Oncology, and Spectrum Pharmaceuticals.

NEUROSCIENCE